The DOI matches its Crossref record.
Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome
Abstract
Insulin resistance has been proposed as the metabolic basis of atherogenesis. This hypothesis is based on the concept of the “insulin resistance syndrome,” according to which insulin resistance is viewed as the primary abnormality that gives rise to dyslipidemia, essential hypertension, impaired glucose tolerance, and NIDDM. However, this hypothesis takes no account of the wellestablished and central role of vascular endothelium in the atherogenic process. Although endothelial injury is an early and prominent feature of atherogenesis, relatively little attention has been given to its metabolic consequences. In subjects with NIDDM, we have shown that endothelial dysfunction is associated with insulin resistance, raising the question of whether this relationship could be causal. In this article, we review the factors that are considered to be responsible for the development of endothelial dysfunction during atherogenesis, together with the metabolic consequences of endothelial dysfunction. While dysfunction of the endothelium in large and medium-sized arteries plays a central role in atherogenesis, we argue that dysfunction of peripheral vascular endothelium, at arteriolar and capillary level, plays the primary role in the pathogenesis of both insulin resistance and the associated features of the insulin resistance syndrome. We propose that the insulin resistance syndrome, together with many aspects of atherogenesis, can be viewed as the diverse consequences of endothelial dysfunction in different vascular beds. This new and testable hypothesis accounts for both the endothelial and metabolic abnormalities associated with atherogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
The Vascular Endothelium and Human Diseases
Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., & Nishigaki, I. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.7502 · Cited by 1,467
The endocrine function of adipose tissue: an update
Ronti, T., Lupattelli, G., & Mannarino, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02474.x · Cited by 902
Minireview: Adiposity, Inflammation, and Atherogenesis
Lyon, C. J., Law, R. E., & Hsueh, W. A. (2003) · Endocrinology · doi:10.1210/en.2003-0285 · Cited by 761
Vascular complications in diabetes mellitus: the role of endothelial dysfunction
Schalkwijk, C. G., & Stehouwer, C. D. A. (2005) · Clinical Science · doi:10.1042/cs20050025 · Cited by 657
Self-citationBiomarkers of Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus
Meigs, J. B. (2004) · JAMA · doi:10.1001/jama.291.16.1978 · Cited by 643
“In addition to vascular insulin resistance, endothelial dysfunction is associated with impaired fibrinolysis, microalbuminuria, impaired function of insulin-sensitive lipoprotein lipase (contributing to a dyslipidemia with high triglyceride and low high-density cholesterol levels), impaired fibrinolysis, and impaired…”
BackgroundLiu, S., Manson, J. E., Buring, J. E., Stampfer, M. J., Willett, W. C., & Ridker, P. M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.3.492 · Cited by 594
Effects of exercise and diet on chronic disease
Roberts, C. K., & Barnard, R. J. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00852.2004 · Cited by 556
Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study
Meigs, J. B., Mittleman, M. A., Nathan, D. M., Tofler, G. H., Singer, D. E., Murphy-Sheehy, P. M., Lipinska, I., D'Agostino, R. B., & Wilson, P. W. F. (2000) · JAMA · doi:10.1001/jama.283.2.221 · Cited by 538
Black, P. H. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00048-5 · Cited by 502
Environmental Cardiology: Studying Mechanistic Links Between Pollution and Heart Disease
Bhatnagar, A. (2006) · Circulation Research · doi:10.1161/01.res.0000243586.99701.cf · Cited by 452
Diabetes mellitus as a prothrombotic condition
Grant, P. J. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01824.x · Cited by 443
The Role of Oxidative Stress in the Pathophysiology of Gestational Diabetes Mellitus
Lappas, M., Hiden, U., Desoye, G., Froehlich, J., Mouzon, S. H.-D., & Jawerbaum, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3765 · Cited by 442
Endothelial dysfunction and pathogenesis of diabetic angiopathy
Stehouwer, C. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00272-6 · Cited by 441
Self-citationEndothelial Dysfunction in Obesity and Insulin Resistance: A Road to Diabetes and Heart Disease
Caballero, A. E. (2003) · Obesity Research · doi:10.1038/oby.2003.174 · Cited by 416
Bouïs, D., Hospers, G. A. P., Meijer, C., Molema, G., & Mulder, N. H. (2001) · Angiogenesis · doi:10.1023/a:1012259529167 · Cited by 379
Blood flow and muscle metabolism: a focus on insulin action
Clark, M. G., Wallis, M. G., Barrett, E. J., Vincent, M. A., Richards, S. M., Clerk, L. H., & Rattigan, S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00408.2002 · Cited by 359
Tran, L. T., Yuen, V. G., & McNeill, J. H. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0184-4 · Cited by 356
Fasting Plasma Homocysteine Levels in the Insulin Resistance Syndrome
Meigs, J. B., Jacques, P. F., Selhub, J., Singer, D. E., Nathan, D. M., Rifai, N., D’Agostino, R. B., & Wilson, P. W. F. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1403 · Cited by 343
Carroll, S., & Dudfield, M. (2004) · Sports Medicine · doi:10.2165/00007256-200434060-00004 · Cited by 327
Roberts, C. K., Barnard, R. J., Sindhu, R. K., Jurczak, M., Ehdaie, A., & Vaziri, N. D. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.022 · Cited by 322
“Metabolic syndrome, otherwise known as syndrome X or insulin resistance syndrome, is defined by the presence of insulin resistance, hyperinsulinemia, and some combination of obesity, dyslipidemia, inflammation, endothelial dysfunction, and hypertension [1-9].”
BackgroundPathophysiological implications of insulin resistance on vascular endothelial function
Wheatcroft, S. B., Williams, I. L., Shah, A. M., & Kearney, M. T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00869.x · Cited by 306
Risérus, U., Basu, S., Jovinge, S., Fredrikson, G. N., Ärnlöv, J., & Vessby, B. (2002) · Circulation · doi:10.1161/01.cir.0000033589.15413.48 · Cited by 292
Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes
Odegaard, A. O., Jacobs, D. R., Sanchez, O. A., Goff, D. C., Reiner, A. P., & Gross, M. D. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0369-6 · Cited by 286
“Lastly, clinical and experimental studies suggest that endothelial dysfunction, likely in the capillary and arteriolar endothelium, which are metabolically involved with insulin-sensitive tissues, is the controlling factor for the amount of insulin that effectively reaches the tissues [50].”
BackgroundAntioxidants, diabetes and endothelial dysfunction
Laight, D. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00054-7 · Cited by 267
Microvascular Function Relates to Insulin Sensitivity and Blood Pressure in Normal Subjects
Serné, E. H., Stehouwer, C. D. A., ter Maaten, J. C., ter Wee, P. M., Rauwerda, J. A., Donker, A. J. M., & Gans, R. O. B. (1999) · Circulation · doi:10.1161/01.cir.99.7.896 · Cited by 263
Self-citationAyala, J. E., Bracy, D. P., Julien, B. M., Rottman, J. N., Fueger, P. T., & Wasserman, D. H. (2007) · Diabetes · doi:10.2337/db06-0883 · Cited by 237
Yudkin, J. S., Juhan-Vague, I., Hawe, E., Humphries, S. E., di Minno, G., Margaglione, M., Tremoli, E., Kooistra, T., Morange, P. E., Lundman, P., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2004.02.004 · Cited by 153
Self-citationLai, J. S., Pang, W. W., Cai, S., Lee, Y. S., Chan, J. K. Y., Shek, L. P. C., Yap, F. K. P., Tan, K. H., Godfrey, K. M., van Dam, R. M., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.03.022 · Cited by 132
Prior, S. J., Goldberg, A. P., Ortmeyer, H. K., Chin, E. R., Chen, D., Blumenthal, J. B., & Ryan, A. S. (2015) · Diabetes · doi:10.2337/db14-1771 · Cited by 107
“This reduction in CD decreases the available surface area for diffusion of glucose into the interstitium (6,7) and may also limit insulin action (8).”
BackgroundNakamura, T., Takano, H., Umetani, K., Kawabata, K.-I., Obata, J.-E., Kitta, Y., Kodama, Y., Mende, A., Ichigi, Y., Fujioka, D., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.012 · Cited by 90
Vascular aging: implications for cardiovascular disease and therapy
Ghebre, Y. T., Yakubov, E., Wong, W. T., & Krishnamurthy, P. (2016) · Translational Medicine · doi:10.4172/2161-1025.1000183 · Cited by 87
“Dysfunctional endothelium increases the risk of developing insulin resistance, which further augments the risk for hypertension, type 2 diabetes and other metabolic syndromes [116,118].”
BackgroundInsulin resistance and the metabolic syndrome—or the pitfalls of epidemiology
Yudkin, J. S. (2007) · Diabetologia · doi:10.1007/s00125-007-0711-3 · Cited by 75
Self-citationDevelopment of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system
Kalia, A., & Gauttam, V. (2013) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/2231-4040.111527 · Cited by 66
The metabolic syndrome and endothelial dysfunction: Common highway to type 2 diabetes and CVD?
Diamant, M., & Tushuizen, M. E. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0061-4 · Cited by 64
Chan, J. L., Bullen, J., Stoyneva, V., DePaoli, A. M., Addy, C., & Mantzoros, C. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1921 · Cited by 60
Matrix metalloproteinase 9 opposes diet-induced muscle insulin resistance in mice
Kang, L., Mayes, W. H., James, F. D., Bracy, D. P., & Wasserman, D. H. (2014) · Diabetologia · doi:10.1007/s00125-013-3128-1 · Cited by 48
Metadata
- Authors
- Pinkney, J. H., Stehouwer, C. D., Coppack, S. W., & Yudkin, J. S.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-09-01
- Volume
- 46
- Issue
- Supplement_2
- Pages
- S9-S13
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2088981742
- Cited by
- 351
- References
- 0
- FWCI
- 8.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.